The National Comprehensive Cancer Network, The US Oncology Network and McKesson Specialty Health collaborate to offer new Value Pathways for cancer care
Saved in:
| Title: | The National Comprehensive Cancer Network, The US Oncology Network and McKesson Specialty Health collaborate to offer new Value Pathways for cancer care |
|---|---|
| Authors: | National Comprehensive Cancer Network (NCCN) |
| Source: | Business Wire (English). 11/29/2012. |
| Abstract: | The National Comprehensive Cancer Network® (NCCN®), The US Oncology Network, and McKesson Specialty Health are collaborating to develop enhanced oncology pathways delivered through innovative technology, which will strengthen standards in evidence-based, high-quality cancer care and enable new forms of transparent provider and payer relationships. Value Pathways powered by NCCN are the next step in a collaboration to deliver a first-of-its-kind clinical quality and regimen support system, building upon a solution initially developed by Proventys, Inc. as CDS Oncology. This workflow-integrated software will allow physicians to assess treatment options consistent with evidence-based standards at the point of care. Value Pathways powered by NCCN, delivered through the clinical quality and regimen support system, is an important step forward in ensuring patients receive the highest quality treatment, while offering options to address the costs of cancer care. [ABSTRACT FROM PUBLISHER] |
| Database: | Regional Business News |
|
Full text is not displayed to guests.
Login for full access.
|
|
| Abstract: | The National Comprehensive Cancer Network® (NCCN®), The US Oncology Network, and McKesson Specialty Health are collaborating to develop enhanced oncology pathways delivered through innovative technology, which will strengthen standards in evidence-based, high-quality cancer care and enable new forms of transparent provider and payer relationships. Value Pathways powered by NCCN are the next step in a collaboration to deliver a first-of-its-kind clinical quality and regimen support system, building upon a solution initially developed by Proventys, Inc. as CDS Oncology. This workflow-integrated software will allow physicians to assess treatment options consistent with evidence-based standards at the point of care. Value Pathways powered by NCCN, delivered through the clinical quality and regimen support system, is an important step forward in ensuring patients receive the highest quality treatment, while offering options to address the costs of cancer care. [ABSTRACT FROM PUBLISHER] |
|---|
